TG Therapeutics, Inc. (BIT:1TGTX)
Italy
· Delayed Price · Currency is EUR 40.00
+0.78 (1.99%)
At close: May 2, 2025
TG Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 23.38 | 12.67 | -223.81 | -348.1 | -279.38 | Upgrade
|
| Depreciation & Amortization | 0.07 | 0.21 | 0.3 | 0.28 | 0.16 | Upgrade
|
| Other Amortization | 2.21 | 2.59 | 2.06 | 1.29 | 1.14 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.23 | -2.24 | -0.33 | 0.52 | -0.03 | Upgrade
|
| Stock-Based Compensation | 42.54 | 37.93 | 44.66 | 61.27 | 80.29 | Upgrade
|
| Other Operating Activities | 6.81 | 2.08 | 2.6 | 1.32 | 3.07 | Upgrade
|
| Change in Accounts Receivable | -78.09 | -51.09 | 1.39 | -1.39 | - | Upgrade
|
| Change in Inventory | -66.85 | -36.94 | - | - | - | Upgrade
|
| Change in Accounts Payable | 22.84 | 0.19 | -11.01 | 15.99 | 11.63 | Upgrade
|
| Change in Unearned Revenue | 17.48 | 5.71 | -0.15 | -0.15 | -0.15 | Upgrade
|
| Change in Other Net Operating Assets | -4.68 | -2.53 | 8.13 | -26.67 | -31.24 | Upgrade
|
| Operating Cash Flow | -40.52 | -31.41 | -176.17 | -295.63 | -214.51 | Upgrade
|
| Capital Expenditures | -0.05 | - | -0.01 | -0.4 | -0.36 | Upgrade
|
| Investment in Securities | -0.99 | -50.65 | -20 | 0.07 | -24.15 | Upgrade
|
| Investing Cash Flow | -1.04 | -50.65 | -20.01 | -0.33 | -24.51 | Upgrade
|
| Long-Term Debt Issued | 244.82 | 25 | - | 70 | - | Upgrade
|
| Long-Term Debt Repaid | -107.55 | - | -0.98 | -30 | - | Upgrade
|
| Net Debt Issued (Repaid) | 137.26 | 25 | -0.98 | 40 | - | Upgrade
|
| Issuance of Common Stock | 0.91 | 47.83 | 0.58 | 2.44 | 679.83 | Upgrade
|
| Repurchase of Common Stock | -8.76 | - | - | - | - | Upgrade
|
| Other Financing Activities | -0.89 | -0.13 | - | -1.02 | - | Upgrade
|
| Financing Cash Flow | 128.53 | 72.71 | -0.39 | 41.42 | 679.83 | Upgrade
|
| Net Cash Flow | 86.97 | -9.36 | -196.57 | -254.55 | 440.81 | Upgrade
|
| Free Cash Flow | -40.56 | -31.41 | -176.18 | -296.04 | -214.86 | Upgrade
|
| Free Cash Flow Margin | -12.33% | -13.44% | -6326.18% | -4425.70% | -141357.90% | Upgrade
|
| Free Cash Flow Per Share | -0.25 | -0.21 | -1.30 | -2.24 | -1.86 | Upgrade
|
| Cash Interest Paid | 18.47 | 8.77 | 5.45 | 3.47 | 4.5 | Upgrade
|
| Cash Income Tax Paid | 0.5 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -62.02 | -47.55 | -97.44 | -166.6 | -111.19 | Upgrade
|
| Unlevered Free Cash Flow | -49 | -42.05 | -92.91 | -164.16 | -108.16 | Upgrade
|
| Change in Net Working Capital | 117.98 | 93.3 | 1.63 | 10.04 | 17.47 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.